According to Cocrystal Pharma 's latest financial reports the company's current EPS (TTM) is -HK$17.80. In 2022 the company made an earnings per share (EPS) of -HK$37.01 a decrease over its 2021 EPS that were of -HK$1.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$17.95 | -51.49% |
2022 | -HK$37.01 | 2875% |
2021 | -HK$1.24 | -92.59% |
2020 | -HK$16.79 | -88.08% |
2019 | -HK$140.87 | -13.71% |
2018 | -HK$163.26 | 5733.33% |
2017 | -HK$2.80 | -99.12% |
2016 | -HK$316.64 | 36.5% |
2015 | -HK$231.98 | 340.44% |
2014 | -HK$52.67 | -64.42% |
2013 | -HK$148.02 | -60.13% |
2012 | -HK$371.25 | 58.94% |
2011 | -HK$233.57 | 943.17% |
2010 | -HK$22.39 | |
2009 | N/A | -100% |
2008 | -HK$2.80 |